Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...